SK bioscience-GSK's Covid-19 vaccine meets Phase III trial's goals
SK bioscience and GSK have reported that their Covid-19 vaccine candidate, SKYCovione met the coprimary goals in the Phase III clinical trial.
Source: clinicaltrialsarena.com
Page 3 - Time Data Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Time Data Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Time Data Services Today - Breaking & Trending Today
UT Health San Antonio to study antibiotics for gum disease treatment
The UT Health San Antonio has received a four-year award of $2.4m from the NIH to study usage of antibiotics for periodontal disease.
Source: clinicaltrialsarena.com
Priothera to start Phase IIb/III trial of acute myeloid leukaemia therapy
Priothera has announced plans to commence Phase IIb/III trial of mocravimod in acute myeloid leukaemia patients undergoing allogeneic HSCT.
Source: clinicaltrialsarena.com
Covid-19 restrictions linked to drop in dengue cases in 2020
Covid-19 restrictions resulted in behavioural changes that affected the transmission of other infectious diseases, including dengue virus.
Source: clinicaltrialsarena.com
FSHD Society to enhance trial design with AI technology deployment
The FSHD Society is set to improve clinical trial design for facioscapulohumeral muscular dystrophy by deploying AI technology.
Source: clinicaltrialsarena.com